Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$462M |
| 2 |
AGN
Allergan plc
AGN
|
+$390M |
| 3 |
AT&T
T
|
+$371M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$353M |
| 5 |
NextEra Energy
NEE
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.97B |
| 2 |
Meta Platforms (Facebook)
META
|
+$435M |
| 3 |
Pfizer
PFE
|
+$377M |
| 4 |
GE Aerospace
GE
|
+$354M |
| 5 |
Starbucks
SBUX
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.71% |
| 3 | Consumer Staples | 9.79% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Morningstar
MORN
$7.22B
| $83.4M | 0.08% |
717,570
+34,054
| +5% | +$4.93M |
|
252
Strategic Education
STRA
$1.85B
| $83M | 0.08% |
594,192
+23,800
| +4% | +$3.64M |
|
253
Pacira BioSciences
PCRX
$1.04B
| $82.8M | 0.08% |
2,468,142
+670,804
| +37% | +$27.9M |
|
254
Copa Holdings
CPA
$5.76B
| $82.5M | 0.08% |
1,821,561
+266,800
| +17% | +$22.8M |
|
|
ELME
255
Elme Communities
ELME
$143M
| $81.9M | 0.08% |
3,432,000
-423,400
| -11% | -$12M |
|
256
Shenandoah Telecom
SHEN
$664M
| $81.8M | 0.08% |
1,661,700
+95,100
| +6% | +$4.22M |
|
|
SCHW
257
Charles Schwab
SCHW
$183B
| $81.8M | 0.08% |
2,433,000
+1,534,100
| +171% | +$64.4M |
|
258
Crocs
CROX
$6.14B
| $81.7M | 0.08% |
4,810,111
+8,779
| +0.2% | +$280K |
|
|
CTXS
259
DELISTED
Citrix Systems Inc
CTXS
| $80.9M | 0.08% |
571,779
+44,889
| +9% | +$5.35M |
|
260
RB Global
RBA
$20.4B
| $80.7M | 0.08% |
2,361,803
+1,072,906
| +83% | +$42.9M |
|
261
Artisan Partners
APAM
$2.79B
| $80.5M | 0.08% |
3,748,051
+90,800
| +2% | +$2.72M |
|
262
Ecopetrol
EC
$34.5B
| $80.5M | 0.08% |
8,464,786
+638,000
| +8% | +$10.6M |
|
263
Dr. Reddy's Laboratories
RDY
$9.87B
| $80.5M | 0.08% |
9,975,240
+1,430,830
| +17% | +$11.9M |
|
264
W.W. Grainger
GWW
$65.3B
| $80.4M | 0.08% |
323,600
+10,200
| +3% | +$3.02M |
|
|
CS
265
DELISTED
Credit Suisse Group
CS
| $80.3M | 0.08% |
9,931,596
-1,684,900
| -15% | -$19.6M |
|
266
Ionis Pharmaceuticals
IONS
$8.6B
| $79.8M | 0.08% |
1,688,411
-350,300
| -17% | -$19.5M |
|
|
PCH
267
DELISTED
PotlatchDeltic
PCH
| $79.8M | 0.08% |
2,542,313
-43,400
| -2% | -$1.68M |
|
268
SSR Mining
SSRM
$5.32B
| $79.5M | 0.08% |
6,989,628
+1,085,045
| +18% | +$17.9M |
|
269
Televisa
TV
$1.48B
| $79M | 0.08% |
13,623,058
+1,240,324
| +10% | +$12.1M |
|
270
Arch Capital
ACGL
$34.3B
| $78.2M | 0.08% |
2,748,900
-321,400
| -10% | -$13M |
|
271
DHT Holdings
DHT
$2.99B
| $77.9M | 0.08% |
10,155,369
+487,298
| +5% | +$3.09M |
|
272
FirstService
FSV
$6.48B
| $77.3M | 0.08% |
1,002,793
+32,600
| +3% | +$3.13M |
|
273
Clean Harbors
CLH
$16.5B
| $77.1M | 0.07% |
1,502,635
-375,000
| -20% | -$27.4M |
|
274
Progress Software
PRGS
$1.66B
| $76.8M | 0.07% |
2,398,590
+566,073
| +31% | +$22.8M |
|
275
Edwards Lifesciences
EW
$49.6B
| $76.3M | 0.07% |
1,214,100
+796,410
| +191% | +$57.4M |
|
Similar funds
Renaissance Technologies's Q1 2020 Portfolio in Review
As of Q1 2020, Renaissance Technologies held 4,047 positions worth $103B, down 21% from $130B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Renaissance Technologies's Q1 2020 filing shows 573 new, 1,474 increased, 1,328 reduced and 645 closed positions. Its largest new stake was AT&T: 13,563,699 shares worth $299M. The largest sale was Tesla, an estimated $1.97B.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Staples.
- Renaissance Technologies's largest Q1 2020 buy was AT&T: 13,563,699 shares worth $299M.
- Renaissance Technologies added most to Baidu in Q1 2020, an estimated $462M increase.
- Renaissance Technologies's biggest Q1 2020 reduction was Tesla, cutting an estimated $1.97B.
- Renaissance Technologies fully exited Phillips 66 in Q1 2020, selling an estimated $214M.
- Renaissance Technologies's ten largest holdings make up 15% of its $103B portfolio in Q1 2020.
- Renaissance Technologies opened 573 new positions and closed 645 in Q1 2020.
- Renaissance Technologies's portfolio value fell 21% quarter-over-quarter to $103B.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.